Max Planck Institute of Psychiatry
Munich, Bavaria, Germany
Psychiatric hospital in Munich, Bavaria
Kraepelinstraße 2-10, 80804 München
About Max Planck Institute of Psychiatry
The Max Planck Institute of Psychiatry is a scientific institute based in the city of Munich in Germany specializing in psychiatry. Currently directed by Elisabeth Binder and Alon Chen, it is one of the 81 institutes in the Max Planck Society.
- Top Sponsors
- Top Collaborators
- Trials By Phase
- Recruitment Status
- Top Conditions
- Intervention Types
- Top Intervention Names
- Trials By Gender
Lead Sponsor
# Trials
Clinical Trials at Max Planck Institute of Psychiatry
During the past decade, Max Planck Institute of Psychiatry conducted 6 clinical trials. In the 10-year time frame, 6 clinical trials started and 1 clinical trials were completed, i.e. on
average, 16.7% percent of trials that started reached the finish line to date. In the past 5 years, 2 clinical trials started and 0 clinical trials were completed. i.e. 0%
of trials that started reached the finish line.
Trials List
Trail ID
Brief Title
Start Date
Completion Date
Status
Enrollment
Biospecimen and Medical Data Collection and Tumor Biopsy in Creating Research Tissue Registry in Patients With Inflammatory or Invasive Breast Cancer
2007-04-17
2030-04-30
Recruiting
1,200
Carboplatin, Paclitaxel and Gemcitabine Hydrochloride With or Without Bevacizumab After Surgery in Treating Patients With Recurrent Ovarian, Epithelial, Primary Peritoneal, or Fallopian Tube Cancer
2007-12-06
Active, not recruiting
1,052
Radiation Therapy Regimens in Treating Patients With Limited-Stage Small Cell Lung Cancer Receiving Cisplatin and Etoposide
2008-03-01
Active, not recruiting
731
Levonorgestrel-Releasing Intrauterine System in Treating Patients With Complex Atypical Hyperplasia or Grade I Endometrial Cancer
2008-11-03
2022-11-30
Active, not recruiting
69
Conservative Surgery in Treating Patients With Low-Risk Stage IA2 or IB1 Cervical Cancer
2009-08-25
2024-12-31
Active, not recruiting
137
Combination Chemotherapy With or Without Erlotinib Hydrochloride in Treating Patients With Metastatic or Recurrent Squamous Cell Carcinoma of the Head and Neck
2010-02-05
2020-11-03
Completed
123
First-Line Treatment of Bevacizumab, Carboplatin, and Paclitaxel in Treating Participants With Stage III-IV Ovarian, Primary Peritoneal, and Fallopian Tube Cancer
2010-04-14
2022-09-13
Completed
33
Radiation Therapy With or Without Chemotherapy in Treating Patients With High-Risk Malignant Salivary Gland Tumors That Have Been Removed By Surgery
2011-01-01
2028-10-01
Active, not recruiting
252
Clinical Trials Sponsors and Collaborators
Out of the total clinical trials conducted in "Max Planck Institute of Psychiatry" #1 sponsor was "Max-Planck-Institute of Psychiatry" with 9 trials, followed by "Ludwig-Maximilians - University of Munich" with 2 trials
sponsored, "Affectis Pharmaceuticals AG" with 1 trials sponsored, "Charite University, Berlin, Germany" with 1 trials sponsored and "Chiasma, Inc."
with 1 trials sponsored. Other sponsors include -4 different institutions and
companies that sponsored additional 6 trials in total.
In terms of collaborators to trials, out of the total clinical trials conducted in "Max Planck Institute of Psychiatry"
#1 collaborator was "Dr. Kade/Besins Pharma GmbH, Rigistr. 2, 12277 Berlin" with 1 trials as a collaborator, "FGK Clinical Research GmbH" with 1 trials as a collaborator, "German Research Foundation" with 1 trials as a collaborator, "Ludwig-Maximilians - University of Munich" with 1 trials as a collaborator and "Max-Planck-Institute of Psychiatry" with 1 trials as a collaborator. Other collaborators include -5 different institutions and companies that were
collaborators in the rest 5 trials.
Clinical Trials Conditions at Max Planck Institute of Psychiatry
According to Clinical.Site data, the most researched conditions in "Max Planck Institute of Psychiatry" are
"Major Depression" (3 trials), "Depressive Disorder" (2 trials), "Healthy" (2 trials), "Major Depressive Disorder" (2 trials) and "Schizophrenia" (2 trials). Many other conditions were trialed in "Max Planck Institute of Psychiatry" in a lesser frequency.
Clinical Trials Intervention Types at Max Planck Institute of Psychiatry
Most popular intervention types in "Max Planck Institute of Psychiatry" are "Drug" (8 trials), "Behavioral" (3 trials), "Other" (2 trials) and "Procedure" (1 trials). Other intervention types were less common.
The name of intervention was led by "Placebo" (3 trials), "Venlafaxine" (2 trials), "15 minute counseling interview" (1 trials), "Amitriptyline" (1 trials) and "Amitriptylinoxide" (1 trials). Other intervention names were less common.
Clinical Trials Genders at Max Planck Institute of Psychiatry
The vast majority of trials in "Max Planck Institute of Psychiatry" are
13 trials for "All" genders, 1 trials for "Female" genders and 1 trials for "Male" genders.
Clinical Trials Status at Max Planck Institute of Psychiatry
Currently, there are NaN active trials in "Max Planck Institute of Psychiatry".
undefined are not yet recruiting,
2 are recruiting,
2 are Active, not recruiting,
and undefined are Enrolling by invitation.
In total, there were 10 completed trials in Max Planck Institute of Psychiatry,
undefined suspended trials,
and undefined terminated clinical trials to date.
Out of the total trials that were conducted in Max Planck Institute of Psychiatry, 0 "Phase 1"
clinical trials were conducted, 2 "Phase 2" clinical
trials and 1 "Phase 3" clinical trials were conducted as
well. "Phase 4" trials included 3 trials, and there were
also 7 trials that are defined as “Not Applicable".